About Us

3Dnamics is a biotechnology company founded by top-notch stem cell pioneers and neuroscientists at Johns Hopkins University School of Medicine. Our mission is to improve human health through innovative applications of stem cell technology. Our initial aim is to engineer 3D organoid models of biological systems and diseases using human cells to fulfill unmet medical needs and to accelerate the discovery and development of novel therapeutics and medicines for neurological diseases, including Alzheimer’s, Parkinson’s, and others.

LEARN MORE

 

Organoids

Pluripotent stem cells can develop into human organ-like structures that may serve as relevant models for studying drug actions and responses.

Technology

3Dnamics team has decades of combined experience in stem cell research. We have developed several pluripotent stem cell-based models of neurological disorders, including Parkinson’s disease, schizophrenia, and others. Most recently, we have developed a cell culture system consisting of a novel spinning bioreactor platform, called SpinΩ, and a set of methods for differentiation of pluripotent stem cells into region-specific brain organoids. Together, our technology provides scalable and robust methods to generate disease-specific and organoid models for pre-clinical drug screening and efficacy/toxicity testing.

DISCOVER OUR SCIENCE

 

Join Us

We are looking for motivated individuals with a passion for innovations and discoveries.

Our Services

3Dnamics provides stem cell-related solutions for your research and business.

LEARN MORE

Products

We generate brain organoids and other neuronal sub-types for pre-clinical drug testing.

LEARN MORE

News

Read about our latest news, announcements and progress towards drug discovery.

LEARN MORE

 

Pathway to Success

Funding and support from TEDCO MSCRF, investors, partners, collaborators and people who share our visions and believe in our approaches are enabling us to grow and to reach new heights.